Also, in breast cancer stem cells, Gb3 was found to activate the cSrc/β-catenin signaling pathway, Gb3 was found to correlate with the number of stem cells in breast cancer cell lines, and silencing of GCS was reported to kill the stem cells [146]. This evidence concerns the gene UGCG and breast carcinoma.